May 29, 2026

Results of the Ordinary Shareholders’ Meeting

PDF icon
EN PDF icon
NL
May 28, 2026

Publication of transparency notifications

PDF icon
EN PDF icon
NL
May 20, 2026

Biotalys Announces Closing of Private Placement

PDF icon
EN PDF icon
NL
May 6, 2026

Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors

PDF icon
EN PDF icon
NL
April 29, 2026

Invitation to the ordinary general shareholders meeting

PDF icon
EN PDF icon
NL
April 29, 2026

Biotalys Reports Full-Year 2025 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
April 27, 2026

Biotalys Achieves First U.S. State Registration for EVOCA in Florida

PDF icon
EN PDF icon
NL
April 7, 2026

Biotalys Achieves First Milestone in Bioinsecticide Partnership with Syngenta

PDF icon
EN PDF icon
NL
March 24, 2026

Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting

PDF icon
EN PDF icon
NL
March 17, 2026

Biotalys Announces Changes to its Board of Directors and Executive Committee

PDF icon
EN PDF icon
NL
February 24, 2026

Biotalys Notice of Publication 2025 Annual Report and Financial Results

PDF icon
EN PDF icon
NL
February 9, 2026

Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn

PDF icon
EN PDF icon
NL
January 23, 2026

Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production

PDF icon
EN PDF icon
NL
December 2, 2025

Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA

PDF icon
EN PDF icon
NL
October 31, 2025

EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide

PDF icon
EN PDF icon
NL